2BB score and signals
Verrica Pharmaceuticals Inc.’s current 2BB score is 54 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 45 | Moderate |
| Momentum | 36 | Weakening |
| Financial strength | 27 | Weak |
| Quality | 80 | Very Strong |
| Risk | 50 | Moderate |
Company facts
| CEO | Jayson Rieger |
| Headquarters | West Chester, Pennsylvania, United States |
| Founded | 2013 |
| Employees | 76 |
| 52-week range | $3.28 – $9.82 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-12 | — | -0.442 | — | $7.10M |
| 2026-08-06 | — | -0.3842 | — | $5.85M |
| 2026-05-12 | -0.41 | -0.3871 | $4.29M | $4.61M |
| 2026-03-11 | -0.46 | -0.8102 | $5.09M | $4.62M |
Related companies
2BBBullish & Bearish